Key result
Increasing free [MgADP] by inhibiting creatine kinase with iodoacetamide caused an approximately threefold increase in left ventricular end diastolic pressure and a 38% increase in the time constant of pressure decay in isolated rat hearts.
Why the study?
Does increasing free [MgADP] using iodoacetamide cause diastolic dysfunction in isolated perfused rat hearts?
Does increasing free [MgADP] using iodoacetamide cause diastolic dysfunction in isolated perfused rat hearts?
Effect estimate: threefold increase
Absolute Event Rate: 16% vs 7%
p-value: p=<0.05
Increased intracellular free MgADP contributes significantly to diastolic dysfunction in the intact heart, likely by slowing the rate of cross-bridge cycling.
Elevated MgADP may impair diastolic function in intact hearts; hypothesis-generating for human HFpEF and requires clinical validation.
Sarcomere relaxation depends on dissociation of actin and myosin, which is regulated by a number of factors, including intracellular [MgATP] as well as MgATP hydrolysis products [MgADP] and inorganic phosphate [Pi], pHi, and cytosolic calcium concentration ([Ca2+]c). To distinguish the contribution of MgADP from the other regulators in the development of diastolic dysfunction, we used a strategy to increase free [MgADP] without changing [MgATP], [Pi], or pHi. This was achieved by applying a low dose of iodoacetamide to selectively inhibit the creatine kinase activity in isolated perfused rat hearts. [MgATP], [MgADP], [Pi], and [H+] were determined using 31P NMR spectroscopy. The [Ca2+]c and the glycolytic rate were also measured. We observed an approximately threefold increase in left ventricular end diastolic pressure (LVEDP) and 38% increase in the time constant of pressure decay (P < 0.05) in these hearts, indicating a significant impairment of diastolic function. The increase in LVEDP was closely related to the increase in free [MgADP]. Rate of glycolysis was not changed, and [Ca2+]c increased by 16%, which cannot explain the severity of diastolic dysfunction. Thus, our data indicate that MgADP contributes significantly to diastolic dysfunction, possibly by slowing the rate of cross-bridge cycling.
No takes yet. Share an insight, caveat, or question.
Tian et al. (1997) studied Diastolic dysfunction (n=37). Iodoacetamide vs. Vehicle (H2O) was evaluated on Left ventricular end diastolic pressure (LVEDP) (threefold increase, p=<0.05). Increasing free [MgADP] by inhibiting creatine kinase with iodoacetamide caused an approximately threefold increase in left ventricular end diastolic pressure and a 38% increase in the time constant of pressure decay in isolated rat hearts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: